Eastern & Western Manufacturig Solutions for Late Life Cycle Products

The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from keeping production in the US to localize the supply chain and ensure the speed of delivery. However, the pressures on companies change as a product nears the end of the life cycle, when the process is well established and the goal is to make it cheaply and efficiently in large volumes without compromising on quality.

Choosing a drug manufacturing site based on a product’s point in the life cycle benefits patients, first by enabling rapid, reliable access to new therapeutics, and later by driving down the cost of mature products. The challenge is to find production sites that cater to both the specific priorities faced at different points in the life cycle and the universal requirements that apply to all products at all times.

In this white paper, the experts at Piramal Pharma Solutions explain how a contract development & manufacturing organization can support biopharma companies as their product needs evolve.